Sign In
Buy AYLA
$0.504
+0 (+0%)
At Close: Apr 17, 2023
Os Therapies Posts Wider Loss in Q2
07:04am, Tuesday, 19'th Aug 2025
Os Therapies (OSTX 5.83%), a clinical-stage biotechnology company focused on immunotherapies for rare pediatric cancers, released earnings for Q2 2025 on August 19, 2025. The most important news in th
Ayala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting
01:00pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
REHOVOT, Israel and WILMINGTON, Del., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
02:13pm, Monday, 31'st Oct 2022 Benzinga
Upgrades
Morgan Stanley upgraded the previous rating for Pure Storage Inc (NYSE:PSTG) from Equal-Weight to Overweight. In the second quarter, Pure Storage showed an EPS of $0.32, compared to $0.14 fr
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
02:03pm, Thursday, 20'th Oct 2022 Benzinga
Upgrades
According to Credit Suisse, the prior rating for Hudson Pacific Properties Inc (NYSE:HPP) was changed from Underperform to Neutral. Hudson Pacific Properties earned $0.51 in the second quarte
AutoZone To Rise Over 9%? Plus Roth Capital Slashes PT On This Stock By 96%
12:15pm, Thursday, 20'th Oct 2022 Benzinga
Raymond James raised the price target on AutoZone, Inc. (NYSE: AZO) from $2,350 to $2,500. AutoZone shares fell 0.7% to close at $2,289.80 on Wednesday.
Roth Capital cut Ayala Pharmaceuticals, Inc
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
10:30am, Wednesday, 19'th Oct 2022 GlobeNewswire Inc.
Merger brings U.S. management and presence, cash to develop compelling late-stage asset
AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders
08:56am, Wednesday, 19'th Oct 2022
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) and Advaxis, Inc. is fair to Ayala sharehold
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
09:10am, Wednesday, 28'th Sep 2022 Benzinga
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducte
Corcept (CORT) Up More Than 20% in Past 3 Months: Here's Why
06:10pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Corcept's (CORT) Cushing's syndrome drug, Korlym, is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.
Ayala Pharmaceuticals, Inc. (AYLA) Upgraded to Buy: Here's Why
04:00pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Ayala Pharmaceuticals, Inc. (AYLA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ayala Pharmaceuticals, Inc. (AYLA) Upgraded to Buy: Here's Why
01:32pm, Tuesday, 13'th Sep 2022
Ayala Pharmaceuticals, Inc. (AYLA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
09:14am, Tuesday, 13'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM)
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
04:45pm, Monday, 12'th Sep 2022 Benzinga
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Phar
